Indian Institute of Science Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00280111
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

live attenuated chimeric japanese encephalitis vaccine (1 trial)

Drugs in Phase 1 Trials (1)

human rotavirus, live attenuated (Rotarix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Encephalitis (Phase 4)

Encephalitis, Japanese (Phase 4)

Rotavirus Infections (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2